Dr. Adrian Boström (@bostrom_adrian) 's Twitter Profile
Dr. Adrian Boström

@bostrom_adrian

MD, PhD | RTs, following≠endorsements | Views my own - not my employer | Father, forgive them; for they do not know what they are doing

ID: 1468524721059024897

calendar_today08-12-2021 10:16:00

1,1K Tweet

159 Followers

188 Following

James C.Coyne (@coyneoftherealm) 's Twitter Profile Photo

"While several medications [for child obesity] demonstrated greater weight loss than placebo, the totality of the evidence was found to be inadequate. An important limitation of the pharmacotherapy studies was that there was only a single trial for each effective medication (ie,

James C.Coyne (@coyneoftherealm) 's Twitter Profile Photo

NCI: Large analysis finds that for healthy adults, taking multivitamins daily is not associated with a lower risk of death. medicalxpress.com/news/2024-06-l…

George Dawson (@dawso007) 's Twitter Profile Photo

Don't know if others were aware of the passing of James C.Coyne a frequent poster here and elsewhere. Here is his obit legacy.com/us/obituaries/…

David Spiegelhalter (@d_spiegel) 's Twitter Profile Photo

My polemic in Nature on probability has attracted some attention nature.com/articles/d4158… - you should be able to download from here rdcu.be/d41qA

Zane Koch (@zanehkoch) 's Twitter Profile Photo

WHY DOES THE EPIGENETIC CLOCK TICK? While money has been poured into developing therapies to reverse the epigenetic clock (Altos Labs 🤑), why the epigenome changes with age at all is unclear. In Nature Aging today, we suggest a potential driver: somatic mutations.

WHY DOES THE EPIGENETIC CLOCK TICK?

While money has been poured into developing therapies to reverse the epigenetic clock (<a href="/altos_labs/">Altos Labs</a> 🤑), why the epigenome changes with age at all is unclear.

In <a href="/NatureAging/">Nature Aging</a> today, we suggest a potential driver: somatic mutations.
Mikael Landen (@plandenm) 's Twitter Profile Photo

Bipolar disorder and artistic temperament: Mechanisms Linking Creativity and bipolar disorder. sciencedirect.com/science/articl…

psychopharmacopeia (@psypharmacopeia) 's Twitter Profile Photo

Anti-psychiatry has plenty of brilliant minds who can tear the field apart with philosophy, rhetoric, and clever arguments. But none of that survives a single shift in a psych ER.

Simon Kitchen (@simonkitchen20) 's Twitter Profile Photo

Misdiagnosed as having depression? You’re not alone. Many with bipolar are first told it’s depression and spend years on the wrong treatment​. It’s frustrating, but you're not alone. Keep pushing for a proper psychiatric assessment – the right diagnosis is the first step toward

Anisopoikilocyte (@anisocyte) 's Twitter Profile Photo

Louella Vaughan Ash Paul Yug Shankar UMAPs.org.uk NHS England PA Stephen Nash The Leng review GMC Adam Skeen Adele Drew-Hill The BMJ There’s a real loss, I feel, in teaching medical reasoning at an early stage when you substitute with non-doctors, who do not possess medical reasoning. You need that training to be able to link science back to the patient to start at the foundations of the degree.

JAMA Psychiatry (@jamapsych) 's Twitter Profile Photo

Viewpoint: Target trial emulation can improve observational study validity by applying randomized trial design principles, but it is not a substitute for randomization. ja.ma/4jJzoA1

Chris Aiken, MD (@chrisaikenmd) 's Twitter Profile Photo

Only 10-30% with bipolar take lithium, but 90% of experts in new survey rank it their top choice: pubmed.ncbi.nlm.nih.gov/40505671 Why? Better long-term outcomes, and addresses underlying causes of the disorder in new review by R Post et al: pubmed.ncbi.nlm.nih.gov/40505671

Only 10-30% with bipolar take lithium, but 90% of experts in new survey rank it their top choice:
pubmed.ncbi.nlm.nih.gov/40505671

Why? Better long-term outcomes, and addresses underlying causes of the disorder in new review by R Post et al:
pubmed.ncbi.nlm.nih.gov/40505671
JAMA Psychiatry (@jamapsych) 's Twitter Profile Photo

Esketamine nasal spray as a monotherapy improved depressive symptoms in treatment-resistant depression (TRD) compared to placebo. ja.ma/4mJgwm3

Esketamine nasal spray as a monotherapy improved depressive symptoms in treatment-resistant depression (TRD) compared to placebo. ja.ma/4mJgwm3
JAMA Psychiatry (@jamapsych) 's Twitter Profile Photo

Viewpoint: Patients with psychotic conditions often wish to stop antipsychotics, suggesting a shift to shared deliberation for collaborative management of associated risks. ja.ma/3UXUX55

Viewpoint: Patients with psychotic conditions often wish to stop antipsychotics, suggesting a shift to shared deliberation for collaborative management of associated risks. ja.ma/3UXUX55
The BMJ (@bmj_latest) 's Twitter Profile Photo

Swedish authorities are considering requests for “de-diagnosis services” for autism and ADHD from a new patient group: adults who no longer want their diagnosis bmj.com/content/390/bm…